Gene · 3226
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RETRACTED ARTICLE: A supply chain disruption risk mitigation model to manage COVID-19 pandemic risk. | Environ Sci Pollut Res Int | 2026 | 33400113 | PubTator, text mining | PubMed |
| HOXC10 Protects from Skin Aging by Targeting the FZD6/Wnt/β-Catenin Signaling Pathway. | Research (Wash D C) | 2025 | 41268215 | PubTator, text mining | PubMed |
| Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trial. | Signal Transduct Target Ther | 2025 | 41266303 | PubTator, text mining | PubMed |
| Prevalence and Mutation Analysis of Medium-Chain Acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening in Hefei, China. | Int J Neonatal Screen | 2025 | 41002789 | PubTator, text mining | PubMed |
| AEnet: a practical tool to construct the splicing-associated phenotype atlas at a single cell level. | Gigascience | 2025 | 40990037 | PubTator, text mining | PubMed |
| From lactation to malignancy: A comparison between healthy and cancerous breast gland at single-cell resolution reveals new issues for tumorigenesis. | FEBS Lett | 2025 | 40922505 | PubTator, text mining | PubMed |
| Social Cognitive Theory and Physical Activity: Examining Gender-Based Prediction Patterns and Theoretical Validity. | Sports (Basel) | 2025 | 40863758 | PubTator, text mining | PubMed |
| B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome. | JCI Insight | 2025 | 40857410 | PubTator, text mining | PubMed |
| Maspin/SerpinB5 is a cytoskeleton-binding protein that regulates epithelial cell shape. | Commun Biol | 2025 | 40846899 | PubTator, text mining | PubMed |
| Development and validation of G2M signature-based prognostic model for stratifying colon cancer prognosis. | Discov Oncol | 2025 | 40783878 | PubTator, text mining | PubMed |
| Delineating Tissue-Specific Cell Identity of Oral Mucosa in Humans and Mice From a Single-Cell Perspective. | J Cell Mol Med | 2025 | 40751276 | PubTator, text mining | PubMed |
| Mechanism of Astragaloside-Brucea javanica oil nanoemulsion against oral squamous cell carcinoma through CDK1/MTFR2: Network pharmacology, bioinformatics, and experimental studies. | PLoS One | 2025 | 40748969 | PubTator, text mining | PubMed |
| Multifaceted regulation of the HOX cluster and its implications in oral cancer. | Clin Epigenetics | 2025 | 40676709 | PubTator, text mining | PubMed |
| Innovating Glioma Therapy Using Secretions from Umbilical Cord Mesenchymal Stem Cells to Target Homeobox and Growth Factor Genes. | Int J Hematol Oncol Stem Cell Res | 2025 | 40421391 | PubTator, text mining | PubMed |
| Unleashing virus structural biology: Probing protein and membrane intermediates in the dynamic process of membrane fusion. | QRB Discov | 2025 | 40371173 | PubTator, text mining | PubMed |
| Development and validation of a 16-gene T-cell- related prognostic model in non-small cell lung cancer. | Front Immunol | 2025 | 40260244 | PubTator, text mining | PubMed |
| Landscape of T Cells in Tuberculous Pleural Effusion. | Clin Respir J | 2025 | 40170555 | PubTator, text mining | PubMed |
| Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. | Pharmaceuticals (Basel) | 2025 | 40143207 | PubTator, text mining | PubMed |
| No UCP1 in the kidney. | Mol Metab | 2025 | 40120980 | PubTator, text mining | PubMed |
| How Valid Is Bandura's Social Cognitive Theory to Explain Physical Activity Behavior? | Eur J Investig Health Psychol Educ | 2025 | 39997084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3226/papers?page=2